Literature DB >> 11710926

Impaired ultraviolet-B-induced cytokine induction in xeroderma pigmentosum fibroblasts.

H Suzuki1, W Kalair, G M Shivji, B Wang, P Toto, P Amerio, K H Kraemer, D N Sauder.   

Abstract

Xeroderma pigmentosum is a rare, autosomal recessive disease in which patients develop excessive solar damage at an early age and have a 1000-fold increased risk of developing cutaneous neoplasms. Xeroderma pigmentosum can be classified into seven complementation groups (A-G) with defects in different DNA nucleotide excision repair genes. Xeroderma pigmentosum patients also have impaired immune function including reduced natural killer cell activity and impaired induction of interferon-gamma. We hypothesized that altered cytokine induction may contribute to the immune defect in xeroderma pigmentosum patients. We examined cytokine mRNA expression after ultraviolet B irradiation using reverse transcriptase polymerase chain reaction in fibroblasts derived from five xeroderma pigmentosum patients in complementation groups A, C, and D and in complemented XP-A and XP-D cells. Cytokines interleukin-1beta and interleukin-6 displayed impaired ultraviolet B induction whereas interleukin-8 had normal induction in the xeroderma pigmentosum fibroblasts. Stable complementation of XP-A and XP-D cell lines increased ultraviolet-B-induced interleukin-1beta and interleukin-6 expression. These results demonstrate a deficient response of xeroderma pigmentosum fibroblasts to ultraviolet B in terms of cytokine interleukin-1beta and interleukin-6 induction but normal interleukin-8 induction and exhibit a role for DNA repair in cytokine induction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710926     DOI: 10.1046/j.0022-202x.2001.01525.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

1.  Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.

Authors:  Porcia T Bradford; Alisa M Goldstein; Deborah Tamura; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; Kyoko Imoto; Hiroki Inui; Shin-Ichi Moriwaki; Steffen Emmert; Kristen M Pike; Arati Raziuddin; Teri M Plona; John J DiGiovanna; Margaret A Tucker; Kenneth H Kraemer
Journal:  J Med Genet       Date:  2010-11-19       Impact factor: 6.318

Review 2.  Plantar basal cell carcinoma in a patient with xeroderma pigmentosum: importance of dermoscopy for early diagnosis of nonpigmented skin cancer.

Authors:  G Salerni; N Cecilia; F Cabrini; I Kolm; C Carrera; L Alós; J Malvehy; S Puig
Journal:  Br J Dermatol       Date:  2011-11       Impact factor: 9.302

3.  Basal cell carcinoma arising from xeroderma pigmentosum: a case report and an immunohistochemical study.

Authors:  Sadanori Furudate; Taku Fujimura; Gen-Ichi Tojo; Takahiro Haga; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2013-03-09

4.  Inflammatory landscape in Xeroderma pigmentosum patients with cutaneous melanoma.

Authors:  Asma Chikhaoui; Meriem Jones; Tadeja Režen; Melika Ben Ahmed; Chokri Naouali; Radovan Komel; Mohamed Zghal; Samir Boubaker; Sonia Abdelhak; Houda Yacoub-Youssef
Journal:  Sci Rep       Date:  2022-08-16       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.